Author + information
- Received October 8, 1985
- Revision received December 2, 1985
- Accepted December 11, 1985
- Published online May 1, 1986.
- Valentina Ugolini, MDa,
- James F. Norcross, MD,
- J. Tracy Schreiber, MD,
- Richard E. Kuntz, MD and
- Anne L. Taylor, MD
- ↵aAddress for reprints: Valentina Ugolini, MD, Internal Medicine/Cardiology, H8.116, University of Texas Health Science Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235.
Peritoneovenous shunts have become an accepted mode of therapy for ascites refractory to medical treatment. However, their use is known to be associated with significant morbidity and mortality. Reported is the case of a patient with a Denver shunt who developed massive intracardiac thrombosis and subsequent shunt malfunction, despite preserved shunt patency.
- Received October 8, 1985.
- Revision received December 2, 1985.
- Accepted December 11, 1985.
- American College of Cardiology Foundation